Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Depreciation & Amortization (CF) (2022 - 2025)

Historic Depreciation & Amortization (CF) for MDxHealth (MDXH) over the last 3 years, with Q3 2025 value amounting to $957000.0.

  • MDxHealth's Depreciation & Amortization (CF) rose 1656.52% to $957000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 790000.0%. This contributed to the annual value of $3.1 million for FY2024, which is 3251.59% up from last year.
  • MDxHealth's Depreciation & Amortization (CF) amounted to $957000.0 in Q3 2025, which was up 1656.52% from $946000.0 recorded in Q2 2025.
  • MDxHealth's 5-year Depreciation & Amortization (CF) high stood at $957000.0 for Q3 2025, and its period low was -$1.7 million during Q4 2024.
  • Over the past 3 years, MDxHealth's median Depreciation & Amortization (CF) value was $779000.0 (recorded in 2023), while the average stood at $233875.0.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first tumbled by 1524.97% in 2024, then surged by 4014.81% in 2025.
  • Over the past 3 years, MDxHealth's Depreciation & Amortization (CF) (Quarter) stood at -$1.5 million in 2023, then fell by 15.25% to -$1.7 million in 2024, then soared by 156.03% to $957000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $957000.0 in Q3 2025, compared to $946000.0 in Q2 2025 and $925000.0 in Q1 2025.